Shares of Omega Healthcare Investors, Inc. (OHI) recently rose above the average 12-month analyst target price of $32.62, trading at $32.66 per share. This milestone prompts analysts to consider either downgrading their valuations or raising their price targets, reflecting potential shifts in the company’s fundamentals. The current standard deviation among analyst targets is $3.113, with predictions ranging from $28.00 to $36.00.
In the latest analysis, there are eight different analyst targets contributing to the OHI average. The breakdown of recent ratings includes 2 Strong Buy, 1 Buy, 5 Hold, and no Sell or Strong Sell ratings, resulting in an average rating of 2.38 on a scale where 1 is Strong Buy and 5 is Strong Sell. The data was provided by Zacks Investment Research.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
